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Abstract MuSK is a receptor tyrosine kinase that initiates the
formation of neuromuscular junctions in response to agrin. Little
is known about the ligand-induced activation and kinase-
dependent signalling that leads to the clustering of acetylcholine
receptors. The ectodomain of these molecule is composed of four
Ig-like domains. We describe here the isolation of a novel MuSK
splice variant that lacks the third Ig-like domain in its
ectodomain. The corresponding RNA is the result of alternative
splicing which eliminates two exons. There is 10 times less
mRNA for this shorter form than for the long form of MuSK and
both forms are regulated coordinately. They decrease strongly
after birth and are elevated in denervated muscle. Gene transfer
by muscle injection of MuSK DNA into individual muscle fibers
demonstrates that kinase-induced acetylcholine receptor cluster-
ing caused by overexpression of the two kinases does not depend
on the presence of the third Ig-like domain.
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1. Introduction
Receptor tyrosine kinases at the cell surface are involved in
the regulation of metabolic and signalling pathways and con-
tribute to cell growth, di¡erentiation, migration and apopto-
sis. They contain a cytoplasmic intrinsic kinase domain which
is connected by a transmembrane segment to the ectodomain.
The ectodomain contains one or several copies of immuno-
globulin-like domains, EGF-like domains, cysteine-rich do-
mains or other domains that form ligand binding or regula-
tory domains. Based on their structural characteristics the
tyrosine kinase receptors can be classi¢ed into families [1].
The muscle-speci¢c kinase, called MuSK [2], is unique in
that it is speci¢c to the skeletal muscle cell lineage and is
part of a receptor complex that initiates neuromuscular junc-
tion formation in response to agrin [3]. In genetically engi-
neered mice lacking MuSK, every aspect of synapse formation
appears to be blocked, showing that this protein is necessary
for postnatal life [4,5]. Agrin/MuSK-mediated acetylcholine
receptor (AChR) clustering probably requires ectodomain re-
gions of MuSK [6].
The ectodomain of MuSK contains three immunoglobulin
(Ig)-like domains followed by a C6 box and a fourth Ig-like
domain [2] also recognized recently as a frizzled cysteine-rich
domain [7,8]. MuSK was isolated from human, rat and mouse
muscles (nsk2) and several isoforms with minor di¡erences
resulting from alternative splicing have been described [2,9].
Using RT-PCR we isolated a novel MuSK cDNA, MuSK-
vIgIII, in which the third Ig-like domain is missing. We show
that MuSK-vIgIII transcripts resulting from alternative splic-
ing and expression in muscle are regulated in a similar way to
that observed for the longer, predominant MuSK form. Since
ligand binding or interactions with regulatory proteins could
di¡er between the two isoforms, we injected the corresponding
DNA directly into muscle ¢bers to compare their AChR-clus-
tering activity (Sander et al., submitted). Both MuSK iso-
forms induce AChR clusters upon overexpression independent
of the presence or absence of the IgIII domain.
2. Materials and methods
2.1. Cloning of MuSK cDNA
MuSK cDNA was isolated using RT-PCR (Titan Kit, Boehringer
Mannheim, Germany). Total RNA was prepared from denervated rat
hind leg muscles [10]. The sense primer, CTAGAATTCACCT-
TTCTTCCTGAGCCTGG, contained an EcoRI site in the 5P position
of the ATG and the antisense primer, CTATCTAGACTCCTG-
GGTGTTGTTTGAGC, an XbaI site in the 3P position to the stop
codon. The primer sequences are based on the published sequence of
the rat MuSK cDNA [2]. RT cDNA synthesis was performed at 50‡C.
The PCR ampli¢cation was done according to the supplier’s protocol.
The resulting RT-PCR product consisted of two fragments of around
2500 bp. Both products were subcloned into the pSP72 vector (Prom-
ega, Mannheim, Germany) and sequenced using the ABI Prism
377 DNA Sequencer (Applied Biosystems, Weiterstadt, Germany)
and the ABI Prism BigDye Ready Reaction Terminator Cycle Se-
quencing Kit (Applied Biosystems, Weiterstadt, Germany). Full
length clones corresponded to the MuSK cDNA as published by
Valenzuela et al. [2] and to the IgIII-lacking form, MuSK-vIgIII
cDNA, as shown in Fig. 1.
PCR reactions were performed in a Perkin Elmer Cetus DNA Ther-
mal Cycler 480 (Perkin Elmer, Ueberlingen, Germany).
2.2. Isolation of fragments of the MuSK/nsk2 gene from a 129 SVJ
mouse genomic library
Gene fragments carrying the IgIII exons were isolated by screening
a lambda FIX II mouse (129 SVJ) genomic library (Stratagene, Hei-
delberg, Germany). Hybond-N nylon ¢lters (Amersham Buchler,
Braunschweig, Germany) were lifted and hybridized with a PCR-syn-
thesized 198 bp IgIII-speci¢c probe corresponding to nucleotides 646^
842 of the rat MuSK cDNA [2]. Hybridization was performed at high
stringency (42‡C for 16 h, 50% formamide, 0.5% SDS, 5UDenhardt’s
solution, 50 mM phosphate bu¡er pH 6.5, 200 Wg/ml sonicated sal-
mon sperm DNA). Filters were washed in 2USSC, 0.1% SDS at 42‡C
for 10 min, then in 1USSC, 0.1% SDS at 50‡C for 10 min and ¢nally
in 0.5USSC, 0.1% SDS at 50‡C for 20 min. Six positive clones were
obtained. One clone was digested with HindIII yielding two ca. 6000
bp fragments which were subcloned into pSP72 vector. Both frag-
ments hybridized with the IgIII-speci¢c probe and were further ana-
lyzed (see Fig. 2) employing the following sequencing primers to iden-
tify exon/intron borders: a1 (CTGCGTGCTCCTGAATCC), a2 (C-
AGCAGGAACAGTTCAGAGCC), a3 (GCTCAGTGTGTCCTGG-
GGTG), b1 (GGTCGGGATAGGAGGTGTTG), b2 (GTCTCGAT-
CACCCATGTGTG), b3 (CCACAGAGCGACCCAGGGTCC).
2.3. Determination of the exon distance by long-PCR
PCR was performed with the primers a3 and b2 using the isolated
lambda clone as a template that contains the IgIII exons. For the
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PCR reaction, two mixtures were prepared. One mixture contained
1 Wl of each primer (20 WM) and 7 Wl of dNTPs (350 WM) and 16 Wl
H2O. A second mixture contained 5 Wl reaction bu¡er, 3.5 Wl Mg2Cl2
(1.75 WM), 1 Wl Taq-Polymerase (5 U/Wl), 3 Wl lambda DNA (1 Wg)
and 12.5 Wl H2O. Both mixtures were stored on ice until starting the
following PCR cycles: denaturation at 93‡C for 2 min; the cycle 93‡C
(10 s), 65‡C (30 s) and 68‡C (10 min) was repeated 10 times. The cycle
93‡C (10 s), 65‡C (30 s) and 68‡C (10 min) with an additional elon-
gation time of 20 s of each cycle was repeated 15 times ¢nally fol-
lowed by an elongation time of 7 min.
A ca. 11 kb fragment was obtained and cloned in the pCRII TOPO
vector (Invitrogen B.V., Leek, The Netherlands).
Sequencing with the primers a3 and b2 revealed that exon A and
exon B with their 5P and 3P intron sequences were located on this PCR
fragment.
2.4. MuSK transcript analysis in rat muscle
RT-PCR was started using 5 Wg of total RNA from rat hind leg
muscles, random hexamers as primers and the SuperScript II reverse
transcriptase (Life Technologies GmbH, Eggenstein, Germany). Ali-
quots of this reaction mixture were then employed for the PCR am-
pli¢cation of MuSK cDNA sequences: for the analysis of total MuSK
transcript levels, kinase-speci¢c primers were used together with 1 Wl
of the cDNA reaction mixture (5P sense primer CTCCTGGGT-
GTTGTTTGAGC and 3P antisense primer CTGGTCCTCCAC-
CCCTGTC). PCR conditions were as follows: denaturation at 95‡C
for 2 min; 95‡C (1 min), 65‡C (15 s), 72‡C (7 min), extension at 72‡C
(2 s) of each cycle. In order to estimate the di¡erent transcript levels in
normal (N) and denervated (D) muscle, PCR ampli¢cation was
stopped after di¡erent cycle numbers. The PCR products were ana-
lyzed by agarose gel electrophoresis imaged with the Cybertech CS-1
camera (Cybertech, Berlin, Germany) and evaluated densitometrically
with NIH Image 1.40 software. (Analysis was performed on a Mac-
intosh 7300/200 computer using the public domain NIH Image pro-
gram, written by Wayne Rasband at the US National Institutes of
Health and available from the Internet by anonymous ftp from zip-
py.nimh.nih.gov or on £oppy disk from NTIS, 5285 Port Royal Rd.,
Spring¢eld, VA 22161, USA, part number PB93-504868.)
As shown in Fig. 3A,B, with increasing cycle numbers (22, 24, 26,
28 cycles) one remained in the exponential phase of ampli¢cation.
The di¡erent transcript levels of MuSK and MuSK-vIgIII in N and
D muscle or at di¡erent developmental stages, at embryonic days 17
and 19 (E17 and E19), and at postnatal day 1 (P1), were estimated in
a similar way using a 5P sense primer GCAAAAGGAAGACGCAG-
GAC and a 3P antisense primer GGTCGGGATAGGAGGTGTTG,
revealing that the two isoforms yielded two di¡erently sized PCR
products. PCR was performed and analyzed as described above. A
MuSK-vIgIII-speci¢c RT-PCR was performed as described above
with a ‘MuSK-vIgIII’- speci¢c 5P sense primer (GGAAGTGGAG-
GAATGGAGCAA) and a 3P antisense primer (TGGACGG-
GAATGTTGTTATG).
2.5. MuSK cDNA injection into muscle ¢bers
Four to ¢ve week old rats were anesthetized with Nembutal (Ab-
bott Laboratories, North Chicago, IL, USA) at a concentration of 50
mg/kg and DNA was injected as described previously [11] (Sander et
al., submitted).
MuSK and MuSK-vIgIII cDNAs cloned into the expression vector
pRK5 [12] used for injection were puri¢ed by Qiagen column chro-
matography (Qiagen, Hilden, Germany). The ¢nal DNA solutions of
100 ng/Wl contained 90 mM KCl and 15 mg/ml Fast green FCF
(Sigma, Deisenhofen, Germany).
3. Results
3.1. Cloning of a novel MuSK cDNA
Denervated rat muscle contains strongly elevated MuSK
transcript levels [2]. Using total RNA extracted from dener-
vated rat hind leg muscle and RT-PCR to isolate full length
MuSK cDNA, we obtained two di¡erently sized products in-
dicating the presence of at least two di¡erent mRNAs (Fig.
1A). Both RT-PCR products were cloned and sequenced. The
longer form corresponded to the sequence published for rat
MuSK carrying A454 instead of the 8 amino acid insertion
(Fig. 1B). The shorter isoform, on the other hand, had the
8 amino acid insertion replacing A454. In addition, the third
Ig-like domain, IgIII, was completely absent after alternative
splicing to yield MuSK-vIgIII (Fig. 1C). This shorter isoform,
therefore, provided a tool to test the functional importance of
the IgIII domain in MuSK.
3.2. The IgIII domain is located on two exons
In order to ¢nd out whether the MuSK-vIgIII isoform
could result from alternative splicing we used a mouse 129
SVJ genomic library to isolate fragments that carry the exon
sequences encoding the IgIII domain. Rat (MuSK) and mouse
(nsk2) cDNA sequences show 93% similarity. With a hybrid-
ization probe from the rat MuSK cDNA including nucleoti-
des 646^842, six phage colonies were isolated. Digestion and
hybridization with the IgIII-speci¢c probe resulted in two
DNA fragments. Both fragments were subcloned into the
pSP72 plasmid vector. With sequencing primers (a1, a2, a3,
b1, b2, b3) exon sequences and exon borders were determined
(Fig. 2). The nucleotide sequences of splice donor and accep-
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Fig. 1. Cloning of MuSK by RT-PCR. A: Total RNA from dener-
vated rat muscle was used to generate full length cDNA of MuSK.
PCR analysis of the cDNA fragments yields at least two products
of di¡erent sizes shown on the right to the Mr standards (Mr sizes
are indicated). The PCR products were cloned and sequenced. The
apparent size of the PCR products is indicated on the right of the
¢gure. B: The larger PCR product of A, shown schematically,
yielded cDNA corresponding to the published MuSK cDNA [2]
with an alanine residue at position A454 instead of an 8 amino acid
insertion. C: The shorter PCR product of A contained only the ¢rst
two Ig-like domains while the third domain, IgIII, was absent. The
clone isolated carried instead of A454 the 8 amino acid insert as in-
dicated schematically. sp, signal peptide; I^IV, Ig-like domains. C6
box and IgIV correspond to the frizzled cysteine-rich domain, CRD
[7,8].
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tor sites strictly follow the GT-AG rule [13] and demonstrate
that the IgIII domain is encoded by two separate exons. The
two cysteines that form the intramolecular disul¢de bond
within the IgIII domain are separated by 48 amino acids.
3.3. MuSK isoform transcripts
MuSK transcripts were detected by Northern blot analysis
shortly after birth (not shown) but levels decreased rapidly
with postnatal development and they became restricted to
the synaptic region [2,14]. Upon denervation, mRNA levels
were strongly increased and thus appear to be regulated in a
similar way to the activity-sensitive AChR subunit genes [14].
We used total RNA isolated from rat muscle at di¡erent
developmental stages and from adult muscle as well as surgi-
cally denervated muscle for RT-PCR analysis. To estimate
changes of transcript levels during development and to com-
pare the relative amounts of MuSK and MuSK-vIgIII tran-
scripts, increasing numbers of PCR cycles were run in the
range of the exponential increase of PCR products. Fig.
3A,B shows the PCR analysis of total MuSK in adult normal
and denervated muscle con¢rming the strong increase in
MuSK mRNA following surgical denervation. Using primers
that yield di¡erently sized PCR products corresponding to
MuSK and MuSK-vIgIII isoforms reveals that in denervated
muscle the MuSK-vIgIII transcript levels are about 10 times
less abundant than the MuSK transcripts (Fig. 3C). At pre-
natal stages and after birth, transcript levels of both isoforms
were elevated when compared to the levels found in adult
innervated muscle and the ratio of the two isoforms was ap-
parently constant. The ¢nding that MuSK-vIgIII transcript
levels were elevated in embryonic and early postnatal muscle
and upregulated in denervated muscle indicates that both
MuSK isoforms are regulated similarly.
With a ‘vIgIII speci¢c’-primer pair (see Section 2) the
strong denervation-induced transcript increase of MuSK-vIg-
III was con¢rmed (not shown).
3.4. MuSK overexpression in muscle induces AChR clusters
We have developed an e⁄cient DNA injection method
which allows gene transfer into distinct muscle ¢bers of living
animals [11]. MuSK cDNA cloned into the expression vector
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Fig. 3. MuSK transcript levels in rat muscle. Total RNA was ex-
tracted from rat hind leg muscle and analyzed by RT-PCR as de-
scribed in Section 2. A: Total MuSK transcripts in adult innervated
and denervated muscle ampli¢ed by kinase-speci¢c primer pairs as
described in Section 2. After 22^28 PCR cycles, 5 Wl of the PCR
products were applied to estimate MuSK transcript concentrations.
N, PCR products from total RNA from normal, innervated muscle;
D, PCR products from RNA from 5 day denervated muscle. Left
and right lanes, Mr size standards. B: Densitometric evalution of
lanes in A reveals 10-fold higher MuSK transcript levels in surgi-
cally denervated muscle. Normal muscle, black bars; denervated
muscle, white bars. C: PCR products using primer pairs that reveal
the di¡erent IgIII-containing and IgIII-lacking transcript levels. To-
tal RNA was extracted from N, normal innervated muscle, D, de-
nervated muscle, E17 and E19, from embryos at days 17 and 19,
P1, from animals at postnatal day 1. MuSK, white bars; MuSK-
vIgIII, black bars.
Fig. 2. Exon structure of the IgIII domain. Genomic DNA frag-
ments of mouse 129 SVJ embryonic stem cells carrying the IgIII do-
main were isolated. The location of the exon sequences in the
cDNA are shown schematically in A. Amino acid positions are
identical in MuSK and nsk2 cDNA. The genomic exon/intron struc-
ture is outlined schematically in B. The amino-terminal cysteine of
the IgIII domain with its 5P £anking sequences are located on exon
A while the carboxy-terminal cysteine and 3P £anking sequences re-
side on exon B. The sequencing primers are indicated below and are
described in Section 2.
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pRK5 induced, upon injection, the appearance of character-
istic AChR clusters on the transgene expressing muscle ¢ber
probably due to overexpression and the resulting autophos-
phorylation (Sander et al., in preparation). Since Ig-like do-
mains could be part of a regulatory or binding domain inter-
acting with synaptic components, we tested whether MuSK-
vIgIII can still be activated to induce AChR clusters. The
MuSK-induced AChR clusters were indistinguishable suggest-
ing that autophosphorylation and AChR cluster-inducing ac-
tivity do not depend on the presence of the third Ig-like do-
main (Fig. 4).
4. Discussion
MuSK shares homology with a muscle-speci¢c tyrosine ki-
nase cloned from the electric organ of the electric ray Torpedo
californica [15] both having four Ig-like domains and a C6
box. The RTK-like proteins Ror1 and Ror2 [16] have only
three Ig-like domains but, like the Torpedo enzyme, a Kringle
domain adjacent to the transmembrane domain. Dror [17] and
Dnrk [18] in Drosophila have no Ig-like domains but cysteine-
rich domains preceding the Kringle domain. A recent com-
puter search [7,8] revealed that the C6 box and the fourth Ig-
like domain of MuSK can also be viewed as a cysteine-rich
domain (CRD) which is shared by genes of the frizzled family
and has been shown to be necessary for Wnt ligand binding
[19]. Previous cloning experiments revealed the existence of a
number of alternatively spliced MuSK [2] and nsk2 isoforms
[9]. One isoform in rat contained an insertion of eight amino
acids instead of an alanine residue at position 454 and di¡er-
ences were also observed in the carboxy-terminal region of the
mouse MuSK homologue nsk2. The identi¢cation of a novel
splice variant lacking a potential functional binding/regulatory
Ig-like domain provides a ‘natural mutant’ which might help
in understanding the functional roles of the extracellularly
exposed domains.
The Ig-like domain ^ as originally recognized in immuno-
globulins ^ typically contains two conserved cysteine residues
separated by about 70 amino acid residues which form intra-
molecular disul¢de bonds to stabilize the tertiary structure of
the protein. Such structural motifs are found in a variety of
cell surface proteins including cell adhesion molecules as well
as receptor tyrosine kinases. Genomic DNA analysis revealed
that the Ig-like domains either are encoded by single exons or
are located on two exons each encoding one of the two cys-
teine residues on ‘half a domain’ [20] and thus could increase
the variety of alternatively spliced isoforms of proteins be-
longing to the immunoglobulin super gene family.
The MuSK-vIgIII isoform results from splicing events that
eliminate two exons which each carry a ‘half a domain’ of
IgIII. The transcripts of the two MuSK isoforms, as detected
by PCR, are expressed at di¡erent levels. The shorter tran-
scripts are about 10 times less abundant than the predominat-
ing longer transcripts and similar ratios are observed during
late embryonic development (embryonic days E17, E19) and
at birth (P1). Both forms are strongly reduced with further
development. Denervation of the leg muscles in adult animals
has been shown to increase the MuSK transcript levels by
about 10-fold. There is also a signi¢cant increase for
MuSK-vIgIII transcripts indicating that both forms are cor-
respondingly regulated during the developmental stages ana-
lyzed and by muscle activity. This behavior is reminiscent of
the changes observed for the muscle activity-sensitive tran-
scripts of the AChR K, L, Q and N subunits which decrease
after birth and are upregulated upon denervation [21,22] and
indicates that similar regulatory mechanisms could determine
the expression of MuSK and AChR [14].
The availability of the IgIII-lacking variant provides a way
to investigate the functional role of the various motifs of the
MuSK ectodomain. Gene transfer into individual muscle ¢-
bers using both MuSK forms indicates that the IgIII domain
is not required for the basic kinase activation. The kinase is
activated upon overexpression of both receptor tyrosine ki-
nase isoforms and induces AChR clusters in ectopic regions
of muscle.
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